Profile data is unavailable for this security.
About the company
Ainos, Inc. is a diversified healthcare company, which is focused on the development of point-of-care testing (POCT), low-dose VELDONA interferon therapeutics and synthetic Ribonucleic Acid (RNA)-driven preventative medicine. The Company's products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. Its pipeline of products, which are under development, includes VELDONA human drugs, VOC POCT-Ainos Flora, VOC platform-NISD co-development, VOC POCT-Ainos Pen, VOC POCT-CHS430 and Synthetic RNA. VELDONA human drugs are the high-priority programs include oral warts for human immunodeficiency virus seropositive patients, common cold, influenza, Sjogrens syndrome and treatment for mild COVID-19 symptoms.
- Revenue in USD (TTM)93.68k
- Net income in USD-14.56m
- Incorporated1984
- Employees46.00
- LocationAinos Inc8880 Rio San Diego Drive, Ste. 800SAN DIEGO 92108United StatesUSA
- Phone+1 (858) 869-2986
- Websitehttps://www.ainos.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioCardia Inc | 468.00k | -10.34m | 5.44m | 16.00 | -- | -- | -- | 11.63 | -7.04 | -7.04 | 0.3132 | -1.27 | 0.0954 | -- | 4.44 | 29,250.00 | -210.81 | -107.34 | -1,190.90 | -154.17 | -- | -- | -2,208.76 | -1,779.24 | -- | -- | -- | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
| Tron Pharmaceuticals Inc | 1.01m | -549.47k | 5.50m | 50.00 | -- | -- | -- | 5.45 | -0.0034 | -0.0034 | 0.0062 | -0.0508 | -- | -- | -- | 20,191.00 | -- | -- | -- | -- | 60.28 | -- | -110.51 | -- | 0.0417 | -433.32 | -- | -- | 0.3272 | -- | -39.70 | -- | -- | -- |
| Fresh Tracks Therapeutics Inc | 8.01m | -5.69m | 5.55m | 4.00 | -- | 0.5591 | -- | 0.6934 | -1.38 | -1.38 | 1.49 | 1.66 | 0.7326 | -- | -- | 2,001,500.00 | -52.10 | -89.76 | -66.50 | -115.24 | -- | -- | -71.12 | -442.61 | -- | -1,272.00 | 0.00 | -- | 15.31 | 37.62 | 73.02 | -- | -- | -- |
| Hepion Pharmaceuticals Inc | 0.00 | -38.52m | 5.58m | 22.00 | -- | 0.9582 | -- | -- | -9.49 | -9.49 | 0.00 | 1.37 | 0.00 | -- | -- | 0.00 | -117.64 | -61.43 | -145.05 | -68.82 | -- | -- | -- | -- | -- | -3,240.31 | 0.00 | -- | -- | -- | -7.92 | -- | -- | -- |
| TFF Pharmaceuticals Inc | 885.71k | -19.93m | 5.61m | 19.00 | -- | 0.8596 | -- | 6.33 | -10.20 | -10.20 | 0.4371 | 2.11 | 0.0647 | -- | 3.72 | 46,616.32 | -145.46 | -79.57 | -181.57 | -83.41 | -- | -- | -2,249.83 | -8,687.66 | -- | -- | 0.00 | -- | 48.01 | -- | 33.13 | -- | -- | -- |
| HST Global Inc | 0.00 | -141.11k | 5.72m | 1.00 | -- | -- | -- | -- | -0.0269 | -0.0269 | 0.00 | -0.1193 | 0.00 | -- | -- | -- | -29,397.92 | -5,836.01 | -- | -- | -- | -- | -- | -- | -- | -24.24 | -- | -- | -- | -- | -0.7858 | -- | -- | -- |
| Intelligent Bio Solutions Inc | 2.83m | -10.03m | 5.74m | 17.00 | -- | 0.4816 | -- | 2.03 | -64.14 | -64.14 | 4.60 | 3.82 | 0.2041 | 2.69 | 7.77 | 166,299.40 | -72.67 | -80.65 | -107.67 | -224.84 | 23.33 | -- | -356.09 | -948.54 | 1.87 | -- | 0.0451 | -- | 187.51 | 367.97 | -28.00 | -- | -- | -- |
| Transcode Therapeutics Inc | 0.00 | -17.06m | 5.75m | 10.00 | -- | 1.10 | -- | -- | -206.36 | -206.36 | 0.00 | 0.7893 | 0.00 | -- | -- | 0.00 | -264.82 | -133.14 | -721.90 | -181.26 | -- | -- | -- | -- | -- | -148.05 | 0.00 | -- | -- | -- | -5.59 | -- | -- | -- |
| Xenetic Biosciences Inc | 2.44m | -4.47m | 5.77m | 4.00 | -- | 0.6648 | -- | 2.36 | -2.92 | -2.92 | 1.59 | 5.63 | 0.2116 | -- | -- | 611,240.00 | -38.71 | -48.91 | -41.54 | -52.82 | -- | -- | -182.95 | -682.42 | -- | -- | 0.00 | -- | 48.80 | -- | 36.90 | -- | -- | -- |
| CeCors Inc | -100.00bn | -100.00bn | 5.81m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
| Burzynski Research Institute Inc | 0.00 | -1.34m | 5.83m | 2.00 | -- | -- | -- | -- | -0.0102 | -0.0102 | 0.00 | -0.0002 | 0.00 | -- | -- | -- | -62,992.45 | -15,304.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -45.74 | -- | -- | -- |
| NuCana PLC (ADR) | 0.00 | -33.94m | 5.85m | 25.00 | -- | 0.4868 | -- | -- | -303.31 | -303.31 | 0.00 | 5.68 | 0.00 | -- | -- | 0.00 | -72.34 | -41.01 | -125.17 | -48.07 | -- | -- | -- | -- | -- | -- | 0.0324 | -- | -- | -- | 13.71 | -- | -21.70 | -- |
| Ainos Inc | 93.68k | -14.56m | 5.91m | 46.00 | -- | 0.2547 | -- | 63.06 | -3.27 | -3.27 | 0.0206 | 3.69 | 0.0028 | 0.8133 | 1.62 | 2,036.52 | -43.83 | -36.36 | -48.64 | -58.33 | -222.11 | 36.82 | -15,547.49 | -813.63 | 0.2847 | -75.23 | 0.2003 | -- | -96.53 | 9.46 | 1.69 | -- | 66.44 | -- |
| Cyclerion Therapeutics Inc | 0.00 | -10.95m | 6.11m | 1.00 | -- | 0.568 | -- | -- | -4.38 | 0.2904 | 0.00 | 3.97 | 0.00 | -- | -- | 0.00 | -95.95 | -72.70 | -158.12 | -86.96 | -- | -- | -- | -2,565.62 | -- | -- | 0.00 | -- | -100.00 | -- | 30.98 | -- | -- | -- |
| Tenax Therapeutics Inc | 0.00 | -10.10m | 6.23m | 5.00 | -- | 0.501 | -- | -- | -24.52 | -24.52 | 0.00 | 6.35 | 0.00 | -- | -- | 0.00 | -67.96 | -199.16 | -75.66 | -285.64 | -- | -- | -- | -- | -- | -105.12 | 0.0322 | -- | -- | -- | 30.21 | -- | -- | -- |
| Kazia Therapeutics Ltd (ADR) | 15.18k | -13.77m | 6.29m | 12.00 | -- | 0.5936 | -- | 414.27 | -0.835 | -0.835 | 0.0008 | 0.3555 | 0.0007 | -- | 73.97 | -- | -63.98 | -46.35 | -82.39 | -54.75 | -- | -- | -90,714.45 | -497.17 | -- | -- | 0.1297 | -- | 979.43 | -28.31 | 18.19 | -- | -- | -- |
Data as of Jul 03 2024. Currency figures normalised to Ainos Inc's reporting currency: US Dollar USD
1.33%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Two Sigma Securities LLCas of 31 Mar 2024 | 25.59k | 0.41% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 15.33k | 0.24% |
| G1 Execution Services LLCas of 31 Mar 2024 | 12.63k | 0.20% |
| UBS Securities LLCas of 31 Mar 2024 | 11.48k | 0.18% |
| Geode Capital Management LLCas of 31 Mar 2024 | 10.20k | 0.16% |
| Tower Research Capital LLCas of 31 Mar 2024 | 8.47k | 0.14% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 15.00 | 0.00% |
| CWM LLCas of 31 Mar 2024 | 7.00 | 0.00% |
| Arbor Point Advisors LLCas of 31 Mar 2024 | 3.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
